litlas
Log inCreate account

David H. Johnson

Active 1984–2025

Also published as
DAVID H. JOHNSON
157
Papers
58,808
Citations
110
h-index
152
i10-index

Citations

Citations per year for David H. Johnson1943: 1 citations1971: 2 citations1985: 1 citations1986: 2 citations1987: 2 citations1988: 3 citations1989: 10 citations1990: 11 citations1991: 16 citations1992: 32 citations1993: 42 citations1994: 38 citations1995: 63 citations1996: 42 citations1997: 68 citations1998: 56 citations1999: 55 citations2000: 69 citations2001: 76 citations2002: 125 citations2003: 229 citations2004: 284 citations2005: 484 citations2006: 520 citations2007: 597 citations2008: 558 citations2009: 709 citations2010: 645 citations2011: 580 citations2012: 537 citations2013: 549 citations2014: 424 citations2015: 414 citations2016: 418 citations2017: 350 citations2018: 312 citations2019: 991 citations2020: 955 citations2021: 802 citations2022: 578 citations2023: 335 citations2024: 544 citations2025: 211 citations2026: 8 citations1944–1970: no citations, so these years are not shown1972–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,632 citing papers, 30.5% of this breakdownChina: 1,397 citing papers, 9.2% of this breakdownUnited Kingdom: 863 citing papers, 5.7% of this breakdownJapan: 712 citing papers, 4.7% of this breakdownCanada: 690 citing papers, 4.5% of this breakdownItaly: 683 citing papers, 4.5% of this breakdownGermany: 677 citing papers, 4.4% of this breakdownFrance: 590 citing papers, 3.9% of this breakdownNetherlands: 481 citing papers, 3.2% of this breakdownSpain: 438 citing papers, 2.9% of this breakdownAustralia: 336 citing papers, 2.2% of this breakdownSouth Korea: 317 citing papers, 2.1% of this breakdown
0%30.5%Other 22.2%

Institutions

Fields

  • Medicine72.8%
  • Biochemistry, Genetics and Molecular Biology18.3%
  • Immunology and Microbiology1.9%
  • Health Professions1.1%
  • Computer Science0.9%
  • Engineering0.7%
  • Other4.3%

Topics

  • Lung Cancer Treatments and Mutations10.7%
  • Lung Cancer Research Studies6.4%
  • Lung Cancer Diagnosis and Treatment6.2%
  • Cancer Immunotherapy and Biomarkers3%
  • Colorectal Cancer Screening and Detection2%
  • Colorectal Cancer Treatments and Studies1.9%
  • Other69.8%

Coauthors

All papers

Open in search
  1. Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

    Authors: Alan Sandler, Robert J. Gray, Michael C. Perry, Julie R. Brahmer, Joan H. Schiller, Afshin Dowlati, Rogério Lilenbaum, David H. Johnson - New England Journal of Medicine 2006 cited by 5,778

  2. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    Authors: Nasser H. Hanna, Bryan J. Schneider, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Laurie E. Gaspar, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, Ishmael Jaiyesimi, David H. Johnson, Natasha B. Leighl, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Navneet Singh, David R. Spigel, Janis O. Stabler, Joan Tashbar, Gregory A. Masters - Journal of Clinical Oncology 2020 cited by 455

  3. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

    Authors: Joan H. Schiller, David Harrington, Chandra P. Belani, Corey J. Langer, Alan Sandler, James E. Krook, Junming Zhu, David H. Johnson - New England Journal of Medicine 2002 cited by 4,984

  4. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

    Authors: Kathy S. Albain, Ruth Swann, Valerie W. Rusch, Andrew T. Turrisi, Frances A. Shepherd, Colum J Smith, Yuhchyau Chen, Robert B. Livingston, Richard H. Feins, David R. Gandara, Willard A. Fry, Gail Darling, David H. Johnson, Mark R. Green, Robert C. Miller, Joanne Ley, W. Sause, James D. Cox - The Lancet 2009 cited by 1,474

  5. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

    Authors: Nasser H. Hanna, Andrew Robinson, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Laurie E. Gaspar, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, Ishmael Jaiyesimi, David H. Johnson, Natasha B. Leighl, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, Navneet Singh, David R. Spigel, Joan Tashbar, Gregory A. Masters - Journal of Clinical Oncology 2021 cited by 301

  6. Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline

    Authors: Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory A. Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael Jaiyesimi - Journal of Clinical Oncology 2022 cited by 124

  7. Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline

    Authors: Navneet Singh, Sarah Temin, Sherman Baker, Elizabeth Blanchard, Julie R. Brahmer, Paul Celano, Narjust Duma, Peter M. Ellis, Ivy B. Elkins, Rami Y. Haddad, Paul J. Hesketh, Dharamvir Jain, David H. Johnson, Natasha B. Leighl, Hirva Mamdani, Gregory A. Masters, Pamela R. Moffitt, Tanyanika Phillips, Gregory J. Riely, Andrew Robinson, Rafael Rosell, Joan H. Schiller, Bryan J. Schneider, David R. Spigel, Ishmael Jaiyesimi - Journal of Clinical Oncology 2022 cited by 113

  8. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

    Authors: Bernard Levin, David A. Lieberman, Beth G. McFarland, Kimberly Andrews, Durado Brooks, John H. Bond, Chiranjeev Dash, Francis M. Giardiello, Seth N. Glick, David H. Johnson, C. Daniel Johnson, Theodore R. Levin, Perry J. Pickhardt, Douglas K. Rex, Robert A. Smith, Alan G. Thorson, Sidney J. Winawer - Gastroenterology 2008 cited by 3,007

  9. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer

    Authors: Sarah Burdett, Jean‐Pierre Pignon, Jayne F. Tierney, Hélène Tribodet, Lesley Stewart, C. Le Péchoux, Anne Aupérin, Thierry Le Chevalier, Richard Stephens, R. Arriagada, Julian P. T. Higgins, David H. Johnson, Jan P. van Meerbeeck, Mahesh Parmar, Robert L. Souhami, Bengt Bergman, Jean-Yves Douillard, Ariane Dunant, Chiaki Endo, D.J. Girling, Harubumi Kato, Steven M. Keller, Hideki Kimura, Aija Knuuttila, Ken Kodama, Ritsuko Komaki, Mark G. Kris, Thomas E. Lad, Tommaso Claudio Mineo, Steven Piantadosi, Rafael Rosell, Giorgio V. Scagliotti, Lesley Seymour, Frances A. Shepherd, Richard Sylvester, Hirohito Tada, Fumihiro Tanaka, Valter Torri, David Waller, Ying Liang, for the Non-Small Cell Lung Cancer Collaborative Group - Cochrane Database of Systematic Reviews 2015 cited by 366

  10. Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

    Authors: Andrew T. Turrisi, KyungMann Kim, Ronald H. Blum, William T. Sause, Robert B. Livingston, Ritsuko Komaki, Henry Wagner, Seena C. Aisner, David H. Johnson - New England Journal of Medicine 1999 cited by 1,498

  11. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data

    Authors: R Arriagada, R. Arriagada, A. Aupérin, Sarah Burdett, Julian P. T. Higgins, David H. Johnson, Thierry Le Chevalier, C. Le Péchoux, M.K.B. Parmar, Jean‐Pierre Pignon, R L Souhami, Richard Stephens, Lesley Stewart, Jayne F. Tierney, Hélène Tribodet - The Lancet 2010 cited by 630

  12. Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

    Authors: Jenny C. Taylor, Hilary C. Martin, Stefano Lise, John Broxholme, Jean‐Baptiste Cazier, Andy Rimmer, Alexander Kanapin, Gerton Lunter, Simon Fiddy, Chris Allan, A.R. Aricescu, Moustafa Attar, Christian Babbs, Jennifer Becq, David Beeson, Celeste Bento, P Bignell, Edward Blair, Veronica J. Buckle, Katherine R. Bull, Ondřej Cais, Holger Cario, Helen Chapel, Richard R. Copley, Richard J. Cornall, Jude Craft, Karin Dahan, Emma E. Davenport, Calliope A. Dendrou, Olivier Devuyst, Aimée L Fenwick, Jonathan Flint, Lars Fugger, Rodney D. Gilbert, Anne Goriely, Angie Green, Ingo H. Greger, Russell Grocock, Anja V. Gruszczyk, Robert Hastings, Edouard Hatton, Douglas R. Higgs, Adrian V. S. Hill, Chris Holmes, Malcolm F. Howard, Linda Hughes, Peter Humburg, David H. Johnson, Fredrik Karpe, Zoya Kingsbury, Usha Kini, Julian C. Knight, Jonathan Krohn, Sarah Lamble, Craig B. Langman, Lorne Lonie, Joshua Luck, Davis J. McCarthy, Simon J. McGowan, Mary Frances McMullin, Kerry A. Miller, Lisa Murray, Andrea H. Németh, M. Andrew Nesbit, David Nutt, Elizabeth Ormondroyd, Annette Oturai, Alistair T. Pagnamenta, Smita Y. Patel, Melanie J. Percy, Nayia Petousi, Paolo Piazza, Siân E. Piret, Guadalupe Polanco‐Echeverry, Niko Popitsch, Fiona Powrie, Christopher W. Pugh, Lynn Quek, Peter A. Robbins, Kathryn Robson, Alexandra Russo, Natasha Sahgal, Pauline A. van Schouwenburg, Anna Schuh, Earl D. Silverman, Alison Simmons, Per Soelberg Sørensen, Elizabeth Sweeney, John Taylor, Rajesh V. Thakker, Ian Tomlinson, Amy Trebes, Stephen R.F. Twigg, Holm H. Uhlig, Paresh Vyas, Tim J. Vyse, Steven A. Wall, Hugh Watkins, Michael P. Whyte, Lorna Witty and 10 more - Nature Genetics 2015 cited by 388

  13. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Authors: Nasser H. Hanna, David H. Johnson, Sarah Temin, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Giuseppe Giaccone, Paul J. Hesketh, Ishmael Jaiyesimi, Natasha B. Leighl, Gregory J. Riely, Joan H. Schiller, Bryan J. Schneider, Thomas J. Smith, Joan Tashbar, William A. Biermann, Gregory A. Masters - Journal of Clinical Oncology 2017 cited by 650

  14. Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition

    Authors: Gregory A. Curt, William Breitbart, David Cella, Jerome E. Groopman, Sandra J. Horning, Loretta M. Itri, David H. Johnson, Christine Miaskowski, Susan L. Scherr, Russell K. Portenoy, Nicholas J. Vogelzang - The Oncologist 2000 cited by 1,253

  15. "Zen 4": The AMD 5nm 5.7GHz x86-64 Microprocessor Core

    Authors: Benjamin Munger, Kathy Wilcox, Jeshuah Sniderman, Chuck Tung, Brett C. Johnson, Russell Schreiber, Carson Henrion, Kevin Gillespie, Tom Burd, Harry D. Fair, David H. Johnson, Jonathan M. White, Scott McLelland, Steven Bakke, Javin Olson, Ryan McCracken, Matthew D. Pickett, Aaron Horiuchi, Hien Nguyen, Tim H Jackson - IEEE International Solid- State Circuits Conference (ISSCC) 2023 cited by 29

  16. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels*

    Authors: Edward A. Panacek, John C. Marshall, Timothy E. Albertson, David H. Johnson, Steven B. Johnson, Rodger D. MacArthur, Mark Miller, William Barchuk, Steven Fischkoff, Martin Kaul, Leah Teoh, Lori Van Meter, Lothar Daum, Stanley Lemeshow, Gregory A. Hicklin, Christopher J. Doig - Critical Care Medicine 2004 cited by 384

  17. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Authors: Gregory A. Masters, Sarah Temin, Christopher G. Azzoli, Giuseppe Giaccone, Sherman Baker, Julie R. Brahmer, Peter M. Ellis, Ajeet Gajra, Nancy Rackear, Joan H. Schiller, Thomas J. Smith, John R. Strawn, David Trent, David H. Johnson - Journal of Clinical Oncology 2015 cited by 851

  18. Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

    Authors: David H. Johnson, Louis Fehrenbacher, William Novotny, Roy S. Herbst, John Nemunaitis, David M. Jablons, Corey J. Langer, Russell F. DeVore, Jacques Gaudreault, Lisa A. Damico, Eric Holmgren, Fairooz F. Kabbinavar - Journal of Clinical Oncology 2004 cited by 1,950

  19. Trastuzumab in the Treatment of Advanced Non-Small-Cell Lung Cancer: Is There a Role? Focus on Eastern Cooperative Oncology Group Study 2598

    Authors: Corey J. Langer, Patricia Stephenson, Ann D. Thor, Márk Vangel, David H. Johnson - Journal of Clinical Oncology 2004 cited by 225

  20. Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

    Authors: Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Giorgio V. Scagliotti, Rafael Rosell, Vincent A. Miller, Ronald B. Natale, Joan H. Schiller, Joachim von Pawel, A Płużańska, U. Gatzemeier, John Grous, Judith Ochs, Steven D. Averbuch, Michael Wolf, Pamela Rennie, Abderrahim Fandi, David H. Johnson - Journal of Clinical Oncology 2004 cited by 1,720

  21. Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

    Authors: Charles Butts, Keyue Ding, Lesley Seymour, Philip Twumasi‐Ankrah, Barbara Graham, David R. Gandara, David H. Johnson, Kenneth A. Kesler, Mark A. Green, Mark Vincent, Yvon Cormier, Glenwood Goss, B. Findlay, Michael Johnston, Ming‐Sound Tsao, Frances A. Shepherd - Journal of Clinical Oncology 2009 cited by 433

  22. Trajectories of Health Care Contact Days for Patients With Stage IV Non–Small Cell Lung Cancer

    Authors: Arjun Gupta, Paul Nguyen, Danielle Kain, Andrew Robinson, Amit Kulkarni, David H. Johnson, Carolyn J. Presley, Anne Blaes, Gabrielle B. Rocque, Ishani Ganguli, Christopher M. Booth, Timothy P. Hanna - JAMA Network Open 2024 cited by 28

  23. Body Mass Index and Its Association with Clinical Outcomes for Advanced Non–Small-Cell Lung Cancer Patients Enrolled on Eastern Cooperative Oncology Group Clinical Trials

    Authors: Suzanne E. Dahlberg, Joan H. Schiller, Philip Bonomi, Alan B. Sandler, Julie R. Brahmer, Suresh S. Ramalingam, David H. Johnson - Journal of Thoracic Oncology 2013 cited by 110

  24. A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

    Authors: Jean‐Pierre Pignon, R. Arriagada, Daniel C. Ihde, David H. Johnson, Michael C. Perry, Robert L. Souhami, Ola Brodin, R Joss, Merrill S. Kies, B Lebeau, T Onoshi, Kell Østerlind, Martin H.N. Tattersall, Henry Wagner - New England Journal of Medicine 1992 cited by 1,333